Here are five insights:
1. Zacks currently has a $47.00 price objective on Orthofix’s stock.
2. Orthofix has a market capitalization of $768.75 million, with a one-year low of $29.99 and a one-year high of $42.61.
3. The stock has a 50-day moving average price of $38.36 and a 200-day moving average price of $37.50.
4. Orthofix reported $0.28 earnings per share for the quarter and earned $104.60 million during the quarter. The company’s quarterly revenue was up 4.3 percent compared to the same quarter last year.
5. Orthofix is a global medical device company focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians.
More articles on devices and implants:
MIS Pedicle Screw Systems receive additional clearance for larger diameter pedicle screws
5th Neuro-Spinal Scaffold for spinal cord injury shows improvement at 6 months: 5 key notes
Medtronic launches its AVILA interbody devices in Europe: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
